Produits pharmaceutiques

Patent europeic · EP0271270 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0271270
Numer da la dumonda
EP87310550
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-11-1987
Publitgà
15-06-1988
Concedì
25-03-1992
Stritgà
29-11-2007
Motiv
Durada maximala cuntanschida
Classas IPC
A61K 37/66 (1990.01)
Prioritad
GB A 8628826 02.12.1986
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 28-12-2007

    Durada maximala cuntanschida

    Published in +pat+ No 24 in 2007

  2. 30-04-2001

    Transferì

    Owner
    Beecham Group PLC, Beecham House Great West Road, Brentford/Middx, United Kingdom → Novartis International Pharmaceutical Ltd., Sofia House, 48 Church Street, Hamilton HM 12, Bermuda

    Published in PIDTJ No 8 in 2001

  3. 15-05-1992

    Concedì

    Published in PIDTJ No 9 in 1992

Partidas

Possessur

Novartis International Pharmaceutical Ltd.

Sofia House, 48 Church Street, Hamilton HM 12, BM

Inventur

Cole, Martin

Betchworth Surrey RH3 7AJ, GB

Sutton, David

Epsom Surrey KT18 5XQ, GB

Boyd, Malcolm Richard

Epsom Surrey KT18 5XQ, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.